Environmental exposures and the risk of hepatocellular carcinoma
- PMID: 39813595
- PMCID: PMC11737496
- DOI: 10.1097/HC9.0000000000000627
Environmental exposures and the risk of hepatocellular carcinoma
Abstract
The global epidemiology of HCC is shifting due to changes in both established and emerging risk factors. This transformation is marked by an emerging prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) and type 2 diabetes, alongside traditional risks such as viral hepatitis (HBV and HCV), and exposure to chemical agents like aflatoxin, alcohol, tobacco, and air pollution. This review examines how environmental exposures and evolving liver pathology, exacerbated by lifestyle and metabolic conditions, are contributing to the rising worldwide incidence of HCC. Effective prevention strategies must not only address traditional risk factors through vaccination and therapeutic measures but also confront metabolic and socioeconomic disparities through comprehensive public health efforts. As the burden of liver cancer continues to grow, particularly in resource-limited settings, an expansive and inclusive approach is vital for mitigating its impact across diverse populations.
Copyright © 2025 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Association for the Study of Liver Diseases.
Conflict of interest statement
The authors have no conflicts to report.
Figures
Similar articles
-
Epidemiological and etiological variations in hepatocellular carcinoma.Infection. 2020 Feb;48(1):7-17. doi: 10.1007/s15010-019-01345-y. Epub 2019 Jul 25. Infection. 2020. PMID: 31347138 Review.
-
The Changing Demographics and Epidemiology of Hepatocellular Carcinoma.Clin Liver Dis. 2025 Feb;29(1):1-15. doi: 10.1016/j.cld.2024.08.001. Epub 2024 Oct 28. Clin Liver Dis. 2025. PMID: 39608950 Review.
-
Liver cancer in 2021: Global Burden of Disease study.J Hepatol. 2025 May;82(5):851-860. doi: 10.1016/j.jhep.2024.10.031. Epub 2024 Oct 30. J Hepatol. 2025. PMID: 39481652
-
Epidemiology of Liver Cancer in Africa: Current and Future Trends.Semin Liver Dis. 2020 May;40(2):111-123. doi: 10.1055/s-0039-3399566. Epub 2019 Nov 14. Semin Liver Dis. 2020. PMID: 31726474 Review.
-
Risk of de novo HCC in patients with MASLD following direct-acting antiviral-induced cure of HCV infection.J Hepatol. 2025 Apr;82(4):582-593. doi: 10.1016/j.jhep.2024.09.038. Epub 2024 Oct 3. J Hepatol. 2025. PMID: 39368711
Cited by
-
Roadmap for HCC Surveillance and Management in the Asia Pacific.Cancers (Basel). 2025 Jun 10;17(12):1928. doi: 10.3390/cancers17121928. Cancers (Basel). 2025. PMID: 40563580 Free PMC article.
References
-
- Hepatitis. World Health Organization . Accessed June 1, 2024. https://www.who.int/data/gho/data/themes/chronic-viral-hepatitis
-
- Oyebamiji YO, Ajijolakewu KA, Adebayo IA. Worldwide Prevalence of Aflatoxins in Food and Feed. In: Hakeem KR, Oliveira CAF, Ismail A, eds. Aflatoxins in Food: A Recent Perspective. Springer International Publishing; 2021. 41-65.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials